MET vs. MRSH: MetLife vs. Marsh & McLennan Companies Stock Comparison
How do MetLife (MET) and Marsh & McLennan Companies (MRSH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
MetLife (MET) and Marsh & McLennan Companies (MRSH) both belong to the Insurance industry, though MET is classified under Life & Health Insurance while MRSH falls under Insurance Brokers.
| Profile Item | MET | MRSH |
|---|---|---|
| Name | MetLife, Inc. | Marsh & McLennan Companies, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Financials | Financials |
| GICS Industry Group | Insurance | Insurance |
| GICS Industry | Insurance | Insurance |
| GICS Sub-Industry | Life & Health Insurance | Insurance Brokers |
| Market Capitalization | 60.95 billion USD | 81.13 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | April 5, 2000 | February 21, 1973 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | MET | MRSH |
|---|---|---|
| Total Return (1Y) | 25.57% | -10.43% |
| Total Return (3Y, Annualized) | 17.75% | -2.39% |
| Total Return (5Y, Annualized) | 13.95% | 3.72% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | MET | MRSH |
|---|---|---|
| Volatility (1Y, Annualized) | 23.59% | 26.36% |
| Beta (5Y) | 0.78 | 0.58 |
| Max Drawdown (5Y) | -35.09% | -34.36% |
| Avg. Volume (3M) | 3.45M | 2.47M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | MET | MRSH |
|---|---|---|
| Sharpe Ratio (1Y) | 0.90 | -0.56 |
| Sortino Ratio (1Y) | 1.28 | -0.78 |
Profitability
ROE (TTM)
Marsh & McLennan Companies (MRSH) at 25.90% sits in the top ROE quartile, while MetLife (MET) at 13.09% is closer to the peer norm — stronger capital efficiency for MRSH.
MET
Insurance industry group
13.09%
- Max
- 38.99%
- Q3
- 22.13%
- Median
- 15.10%
- MET
- 13.09%
- Q1
- 10.16%
- Min
- -3.97%
MRSH
Insurance industry group
25.90%
- Max
- 38.99%
- MRSH
- 25.90%
- Q3
- 22.13%
- Median
- 15.10%
- Q1
- 10.16%
- Min
- -3.97%
Net Margin (TTM)
Marsh & McLennan Companies (MRSH) at 14.24% keeps about the industry-typical share of revenue as profit, while MetLife (MET) at 4.57% retains only a bottom-quartile share.
MET
Insurance industry group
4.57%
- Max
- 37.68%
- Q3
- 19.27%
- Median
- 11.38%
- Q1
- 5.91%
- MET
- 4.57%
- Min
- -10.79%
MRSH
Insurance industry group
14.24%
- Max
- 37.68%
- Q3
- 19.27%
- MRSH
- 14.24%
- Median
- 11.38%
- Q1
- 5.91%
- Min
- -10.79%
Operating Margin (TTM)
Neither side reports a meaningful operating margin: for MetLife (MET) in Insurance and Marsh & McLennan Companies (MRSH) in Insurance, funding costs are part of the core business, so net margin and ROE are the cleaner profitability reads.
Profitability Metrics
| Metric | MET | MRSH |
|---|---|---|
| ROE (TTM) | 13.09% | 25.90% |
| ROA (TTM) | 0.45% | 7.24% |
| Net Margin (TTM) | 4.57% | 14.24% |
| Operating Margin (TTM) | -- | -- |
| Gross Margin (TTM) | -- | -- |
Growth
Revenue Growth
Both MetLife (MET) at 7.88% and Marsh & McLennan Companies (MRSH) at 10.32% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Marsh & McLennan Companies (MRSH) at 3.06% is around its peer norm for EPS growth, while MetLife (MET) at -21.04% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | MET | MRSH |
|---|---|---|
| Revenue Growth (YoY) | 7.88% | 10.32% |
| Revenue Growth (3Y CAGR) | 3.92% | 9.20% |
| EPS Growth (YoY) | -21.04% | 3.06% |
| EPS Growth (3Y CAGR) | 18.50% | 11.75% |
Financial Strength
Current Ratio (MRQ)
current ratio doesn’t apply on either side: MetLife (MET) in Insurance and Marsh & McLennan Companies (MRSH) in Insurance both report balance sheets without a current/non-current split, so their short-term liquidity is better judged through regulatory and funding measures.
Debt / Equity (MRQ)
debt-to-equity ratio is set aside for both: MetLife (MET) in Insurance and Marsh & McLennan Companies (MRSH) in Insurance run businesses where balance-sheet leverage is part of the model, so capital-adequacy and funding measures are the better gauges of balance-sheet risk.
Financial Strength Metrics
| Metric | MET | MRSH |
|---|---|---|
| Current Ratio (MRQ) | -- | -- |
| Debt / Equity (MRQ) | -- | -- |
| Net Debt / EBITDA | -- | -- |
Dividends
Dividend Yield (TTM)
Both MetLife (MET) at 2.37% and Marsh & McLennan Companies (MRSH) at 2.14% pay solid, industry-typical yields, sitting squarely within their peers’ usual range.
MET
Insurance industry group
2.37%
- Max
- 5.37%
- Q3
- 2.46%
- MET
- 2.37%
- Median
- 1.23%
- Q1
- 0.00%
- Min
- 0.00%
MRSH
Insurance industry group
2.14%
- Max
- 5.37%
- Q3
- 2.46%
- MRSH
- 2.14%
- Median
- 1.23%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both MetLife (MET) at 43.97% and Marsh & McLennan Companies (MRSH) at 43.96% pay out an above-typical share of earnings for their industries, leaving thinner cover if profits dip.
MET
Insurance industry group
43.97%
- Max
- 79.14%
- MET
- 43.97%
- Q3
- 34.44%
- Median
- 16.02%
- Q1
- 0.00%
- Min
- 0.00%
MRSH
Insurance industry group
43.96%
- Max
- 79.14%
- MRSH
- 43.96%
- Q3
- 34.44%
- Median
- 16.02%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | MET | MRSH |
|---|---|---|
| Dividend Yield (TTM) | 2.37% | 2.14% |
| Dividend Payout Ratio (TTM) | 43.97% | 43.96% |
Valuation
P/E Ratio (TTM)
MetLife (MET) at 18.52 is near its industry’s usual P/E ratio, while Marsh & McLennan Companies (MRSH) at 21.09 sits in the richer quartile — MRSH needs stronger growth or earnings quality to justify the premium.
MET
Insurance industry group
18.52
- Max
- 29.70
- Q3
- 18.57
- MET
- 18.52
- Median
- 11.71
- Q1
- 8.43
- Min
- 3.23
MRSH
Insurance industry group
21.09
- Max
- 29.70
- MRSH
- 21.09
- Q3
- 18.57
- Median
- 11.71
- Q1
- 8.43
- Min
- 3.23
P/S Ratio (TTM)
MetLife (MET) at 0.77 looks cheap on sales in the lower P/S ratio quartile, while Marsh & McLennan Companies (MRSH) at 2.90 looks rich in the upper quartile — a clear gap in price per dollar of revenue.
MET
Insurance industry group
0.77
- Max
- 4.07
- Q3
- 2.22
- Median
- 1.21
- Q1
- 0.84
- MET
- 0.77
- Min
- 0.08
MRSH
Insurance industry group
2.90
- Max
- 4.07
- MRSH
- 2.90
- Q3
- 2.22
- Median
- 1.21
- Q1
- 0.84
- Min
- 0.08
P/B Ratio (MRQ)
MetLife (MET) at 2.23 sits near its industry’s typical P/B ratio, while Marsh & McLennan Companies (MRSH) at 5.35 prices above its benchmark range — MRSH looks rich relative to book.
MET
Insurance industry group
2.23
- Max
- 3.94
- Q3
- 2.51
- MET
- 2.23
- Median
- 1.78
- Q1
- 1.16
- Min
- 0.42
MRSH
Insurance industry group
5.35
- MRSH
- 5.35
- Max
- 3.94
- Q3
- 2.51
- Median
- 1.78
- Q1
- 1.16
- Min
- 0.42
Valuation Metrics
| Metric | MET | MRSH |
|---|---|---|
| P/E Ratio (TTM) | 18.52 | 21.09 |
| P/S Ratio (TTM) | 0.77 | 2.90 |
| P/B Ratio (MRQ) | 2.23 | 5.35 |
| Free Cash Flow Yield (TTM) | -- | -- |